Zinc-dependent contact system activation induces vascular leakage and hypotension in rodents

Biological Chemistry

Volumn 394, Issue 9, 2013, Pages 1195-1204

  Bjorkqvist, Jenny ^a   Lecher, Bernd ^b   Maas, Coen ^a,c   Renne, Thomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b mfd Diagnostics GmbH   (Germany)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Angioedema; Bradykinin; Coagulation; Inflammation; Kallikrein kinin system

Indexed keywords

BLOOD CLOTTING FACTOR 12; BRADYKININ; COMPLEMENT COMPONENT C1S INHIBITOR; DEXTRAN SULFATE; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; ZINC;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL PARAMETERS; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAVASATION; HUMAN; HYPOTENSION; IN VIVO STUDY; LASER MICROSCOPY; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; VASCULAR LEAKAGE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANIONS; BRADYKININ; CAPILLARY PERMEABILITY; DEXTRAN SULFATE; FACTOR XII; FACTOR XIIA; HUMANS; HYPOTENSION; KALLIKREINS; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, WISTAR; ZINC;

EID: 84881534476     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0144     Document Type: Article

References (53)

1. Baird, T.R. and Walsh, P.N. (2002). Activated platelets but not endothelial cells participate in the initiation of the consoli dation phase of blood coagulation. J. Biol. Chem. 277, 28498- 28503.
2. Bernardo, M.M., Day, D.E., Halvorson, H.R., Olson, S.T., and Shore, J.D. (1993a). Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies. J. Biol. Chem. 268, 12477 - 12483.
3. Bernardo, M.M., Day, D.E., Olson, S.T., and Shore, J.D. (1993b). Surface-independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement. J. Biol. Chem. 268, 12468 - 12476.
4. Blossom, D.B., Kallen, A.J., Patel, P.R., Elward, A., Robinson, L., Gao, G., Langer, R., Perkins, K.M., Jaeger, J.L., Kurkjian, K.M., et al. (2008). Outbreak of adverse reactions associated with contaminated heparin. N. Engl. J. Med. 359, 2674 - 2684.
5. Busse, R. and Fleming, I. (2003). Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces. Trends Pharmacol. Sci. 24, 24 - 29.
6. Cicardi, M., Banerji, A., Bracho, F., Malbran, A., Rosenkranz, B., Riedl, M., Bork, K., Lumry, W., Aberer, W., Bier, H., et al. (2010). Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N. Engl. J. Med. 363, 532 - 541.
7. Cichon, S., Martin, L., Hennies, H.C., Muller, F., Van Driessche, K., Karpushova, A., Stevens, W., Colombo, R., Renne, T., Drouet, C., et al. (2006). Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am. J. Hum. Genet. 79, 1098 - 1104.
8. Citarella, F., Wuillemin, W.A., Lubbers, Y.T., and Hack, C.E. (1997). Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage. Br. J. Haematol. 99, 197- 205.
9. Curd, J.G., Prograis, L.J. Jr., and Cochrane, C.G. (1980). Detection of active kallikrein in induced blister fluids of hereditary angioedema patients. J. Exp. Med. 152, 742 - 747.
10. de Maat, S., van Dooremalen, S., de Groot, P.G., and Maas, C. (2013). A nanobody-based method for tracking factor XII activation in plasma. Thromb Haemost. 109. dx.doi. org/10.1160/TH12-11-0792.
11. Greengard, J.S., Heeb, M.J., Ersdal, E., Walsh, P.N., and Griffin, J.H. (1986). Binding of coagulation factor XI to washed human platelets. Biochemistry 25, 3884 - 3890.
12. Hagedorn, I., Schmidbauer, S., Pleines, I., Kleinschnitz, C., Kronthaler, U., Stoll, G., Dickneite, G., and Nieswandt, B. (2010). Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding. Circulation 121, 1510 - 1517.
13. Han, E.D., MacFarlane, R.C., Mulligan, A.N., Scafidi, J., and Davis, A.E., (2002). Increased vascular permeability in C1 inhibitor - deficient mice mediated by the bradykinin type 2 receptor. J. Clin. Invest. 109, 1057 - 1063.
14. Hasan, A.A., Cines, D.B., Herwald, H., Schmaier, A.H., and Muller- Esterl, W. (1995). Mapping the cell binding site on high molecular weight kininogen domain 5. J. Biol. Chem. 270, 19256 - 19261.
15. Herwald, H., Hasan, A.A., Godovac-Zimmermann, J., Schmaier, A.H., and Muller-Esterl, W. (1995). Identification of an endothelial cell binding site on kininogen domain D3. J. Biol. Chem. 270, 14634 - 14642.
16. Jansen, P.M., Pixley, R.A., Brouwer, M., de Jong, I.W., Chang, A.C., Hack, C.E., Taylor, F.B. Jr., and Colman, R.W. (1996). Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. Blood 87, 2337 - 2344.
17. Johne, J., Blume, C., Benz, P.M., Pozgajova, M., Ullrich, M., Schuh, K., Nieswandt, B., Walter, U., and Renne, T. (2006). Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma. Biol. Chem. 387, 173 - 178.
18. Kannemeier, C., Shibamiya, A., Nakazawa, F., Trusheim, H., Ruppert, C., Markart, P., Song, Y., Tzima, E., Kennerknecht, E., Niepmann, M., et al. (2007). Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc. Natl. Acad. Sci. USA 104, 6388 - 6393.
19. Kishimoto, T.K., Viswanathan, K., Ganguly, T., Elankumaran, S., Smith, S., Pelzer, K., Lansing, J.C., Sriranganathan, N., Zhao, G., Galcheva-Gargova, Z., et al. (2008). Contaminated heparin associated with adverse clinical events and activation of the contact system. N. Engl. J. Med. 358, 2457 - 2467.
20. Kleinschnitz, C., Stoll, G., Bendszus, M., Schuh, K., Pauer, H.U., Burfeind, P., Renne, C., Gailani, D., Nieswandt, B., and Renne, T. (2006). Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J. Exp. Med. 203, 513 - 518.
21. Kluft, C., Trumpi-Kalshoven, M.M., Jie, A.F., and Veldhuyzen-Stolk, E.C. (1979). Factor XII-dependent fibrinolysis: A double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- And kallikrein-dependent plasminogen proactivator. Thromb. Haemost. 41, 756 - 773.
22. Maas, C., Govers-Riemslag, J.W., Bouma, B., Schiks, B., Hazenberg, B.P., Lokhorst, H.M., Hammarstrom, P., Ten Cate, H., de Groot, P.G., Bouma, B.N., et al. (2008). Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J. Clin. Invest. 118, 3208 - 3218.
23. Maas, C., Oschatz, C., and Renne, T. (2011). The plasma contact system 2.0. Semin. Thromb. Hemost. 37, 375 - 381.
24. Magneson, G.R., Puvathingal, J.M., and Ray, W.J. Jr. (1987). The concentrations of free Mg2 + and free Zn2 + in equine blood plasma. J. Biol. Chem. 262, 11140 - 11148.
25. Mahdi, F., Madar, Z.S., Figueroa, C.D., and Schmaier, A.H. (2002). Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood 99, 3585 - 3596.
26. Marx, G. and Eldor, A. (1985). The procoagulant effect of zinc on fibrin clot formation. Am. J. Hematol. 19, 151 - 159.
27. Meloni, F.J., Gustafson, E.J., and Schmaier, A.H. (1992). High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. Blood 79, 1233 - 1244.
28. Morrissey, J.H., Choi, S.H., and Smith, S.A. (2012). Polyphosphate: An ancient molecule that links platelets, coagulation, and inflammation. Blood 119, 5972 - 5979.
29. Motta, G., Rojkjaer, R., Hasan, A.A., Cines, D.B., and Schmaier, A.H. (1998). High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: A novel mechanism for contact activation. Blood 91, 516 - 528.
30. Muller, F., Mutch, N.J., Schenk, W.A., Smith, S.A., Esterl, L., Spronk, H.M., Schmidbauer, S., Gahl, W.A., Morrissey, J.H., and Renne, T. (2009). Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139, 1143 - 1156.
31. Muller, F. and Renne, T. (2011). Platelet polyphosphates: the nexus of primary and secondary hemostasis. Scand. J. Clin. Lab. Invest. 71, 82 - 86.
32. Nielsen, E.W., Johansen, H.T., Hogasen, K., Wuillemin, W., Hack, C.E., and Mollnes, T.E. (1996). Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema. Scand. J. Immunol. 44, 185 - 192.
33. Ojima, M., Hasegawa, E., Kumashiro, O., and Ogawa, T. (1988). Changes in choroidal blood flow following ligation of common carotid artery. Jpn. J. Ophthalmol. 32, 322 - 327.
34. Oschatz, C., Maas, C., Lecher, B., Jansen, T., Bjorkqvist, J., Tradler, T., Sedlmeier, R., Burfeind, P., Cichon, S., Hammerschmidt, S., et al. (2011). Mast cells increase vascular permeability by heparin - initiated bradykinin formation in vivo. Immunity 34, 258 - 268.
35. Palmer, R.M., Ferrige, A.G., and Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature 327, 524 - 526.
36. Reddigari, S.R., Shibayama, Y., Brunnee, T., and Kaplan, A.P. (1993). Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J. Biol. Chem. 268, 11982- 11987.
37. Renne, T., Dedio, J., David, G., and Muller-Esterl, W. (2000). High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells. J. Biol. Chem. 275, 33688 - 33696.
38. Renne, T., Dedio, J., Meijers, J.C., Chung, D., and Muller-Esterl, W. (1999). Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein Evidence for a critical role of apple domain-2. J. Biol. Chem. 274, 25777 - 25784.
39. Renne, T., Gailani, D., Meijers, J.C., and Muller-Esterl, W. (2002). Characterization of the H-kininogen-binding site on factor XI: A comparison of factor XI and plasma prekallikrein. J. Biol. Chem. 277, 4892 - 4899.
40. Renne, T. and Muller-Esterl, W. (2001). Cell surface-associated chondroitin sulfate proteoglycans bind contact phase factor H-kininogen. FEBS Lett. 500, 36 - 40.
41. Renne, T., Schmaier, A.H., Nickel, K.F., Blomback, M., and Maas, C. (2012). In vivo roles of factor XII. Blood 22, 4296 - 4303.
42. Renne, T., Schuh, K., and Muller-Esterl, W. (2005). Local bradykinin formation is controlled by glycosaminoglycans. J. Immunol. 175, 3377 - 3385.
43. Rojkjaer, R. and Schousboe, I. (1997). The surface - dependent autoactivation mechanism of factor XII. Eur. J. Biochem 243, 160 - 166.
44. Samuel, M., Pixley, R.A., Villanueva, M.A., Colman, R.W., and Villanueva, G.B. (1992). Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies. J. Biol. Chem. 267, 19691 - 19697.
45. Schapira, M., Silver, L.D., Scott, C.F., Schmaier, A.H., Prograis, L.J. Jr., Curd, J.G., and Colman, R.W. (1983). Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N. Engl. J. Med. 308, 1050 - 1053.
46. Schmaier, A.H. (2008). The elusive physiologic role of Factor XII. J. Clin. Invest. 118, 3006 - 3009.
47. Siebeck, M., Cheronis, J.C., Fink, E., Kohl, J., Spies, B., Spannagl, M., Jochum, M., and Fritz, H. (1994). Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors. J. Appl. Physiol. 77, 2675 - 2680.
48. Siegerink, B., Govers-Riemslag, J.W., Rosendaal, F.R., Ten Cate, H., and Algra, A. (2010). Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) case-control study. Circulation 122, 1854 - 1861.
49. Smith, S.A., Choi, S.H., Davis-Harrison, R., Huyck, J., Boettcher, J., Reinstra, C.M., and Morrissey, J.H. (2010). Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood 116, 4353 - 4359.
50. van der Meijden, P.E., Munnix, I.C., Auger, J.M., Govers-Riemslag, J.W., Cosemans, J.M., Kuijpers, M.J., Spronk, H.M., Watson, S.P., Renne, T., and Heemskerk, J.W. (2009). Dual role of collagen in factor XII-dependent thrombus formation. Blood 114, 881 - 890.
51. Vu, T.T., Fredenburgh, J.C., and Weitz, J.I. (2013). Zinc: An important cofactor in haemostasis and thrombosis. Thromb. Haemost. 109, 421 - 430.
52. Zhuo, R., Siedlecki, C.A., and Vogler, E.A. (2006). Autoactivation of blood factor XII at hydrophilic and hydrophobic surfaces. Biomaterials 27, 4325 - 4332.
53. Zuraw, B.L. (2008). Clinical practice Hereditary angioedema. N. Engl. J. Med. 359, 1027 - 1036.